EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Multigene assays in early breast cancer: Current evidence, limits and future directions

Emanuela Fina, Vincenzo Di Lauro, Alessandro Rizzo, Samantha Bove, Maria Colomba Comes, Michele De Laurentiis, Raffaella Massafra

Cancer Treatment Reviews · 2026-05 · 146 · 103136

DOI: 10.1016/j.ctrv.2026.103136 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Treatment Reviews, 2026-05. Verfasst von Emanuela Fina und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy. Hauptthemen laut MEDLINE: Breast Neoplasms, Gene Expression Profiling. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 128 Literaturangaben. Gefördert von: Fondazione Umberto Veronesi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent developments in genomic profiling and molecular diagnostics have significantly improved our comprehension of breast cancer, leading to the advent of personalized treatment options. The evolution of genomic assays, including Oncotype DX®, MammaPrint®, Prosigna®, EndoPredict®, and Breast Cancer Index®, along with the collaboration of multidisciplinary teams, signifies a transition toward more customized and effective therapeutic strategies. Our work offers a thorough overview of the advancing strategies in breast cancer management in terms of multigene assay application to the clinical routine, specifically focusing on current evidence, limits and future research directions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsGene Expression ProfilingHumansFemaleBiomarkers, TumorGenomics

Stichwörter der Autor:innen

Artificial intelligenceBreast cancerBreast cancer indexEndoPredictGene signaturesGenomic assaysLiquid biopsyMammaPrintOncotype DXProsigna

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Department of Breast and Thoracic Oncology, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Napoli, Italy.
  • S.S.D. c.O.r.o. Bed Management Presa in Carico, TDM, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy. Electronic address: rizzo.alessandro179@gmail.com.
  • S.S.D. c.O.r.o. Bed Management Presa in Carico, TDM, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
  • Department of Breast and Thoracic Oncology, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Napoli, Italy; Laboratorio di Bioinformatica e Biostatistica, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
  • Scientific Directorate, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Tumori "Giovanni Paolo II", Bari, Italy.

Förderung

  • Fondazione Umberto Veronesi

Zitieren

APA

Fina, E., Lauro, V. D., Rizzo, A., Bove, S., Comes, M. C., Laurentiis, M., & Massafra, R. (2026). Multigene assays in early breast cancer: Current evidence, limits and future directions. Cancer Treatment Reviews, 146, 103136. https://doi.org/10.1016/j.ctrv.2026.103136

Vancouver

Fina E, Lauro VD, Rizzo A, Bove S, Comes MC, Laurentiis M, et al. Multigene assays in early breast cancer: Current evidence, limits and future directions. Cancer Treatment Reviews. 2026;146:103136. doi:10.1016/j.ctrv.2026.103136

BibTeX
@article{Fina2026,
  author = {Fina, Emanuela and Lauro, Vincenzo Di and Rizzo, Alessandro and Bove, Samantha and Comes, Maria Colomba and Laurentiis, Michele De and Massafra, Raffaella},
  title = {Multigene assays in early breast cancer: Current evidence, limits and future directions},
  journal = {Cancer Treatment Reviews},
  year = {2026},
  volume = {146},
  pages = {103136},
  doi = {10.1016/j.ctrv.2026.103136}
}
Kostenlos starten →